These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 8586002

  • 1. Plasma oxidizability in subjects with normal glucose tolerance, impaired glucose tolerance, and NIDDM.
    Haffner SM, Agil A, Mykkanen L, Stern MP, Jialal I.
    Diabetes Care; 1995 May; 18(5):646-53. PubMed ID: 8586002
    [Abstract] [Full Text] [Related]

  • 2. Plasma oxidizability in Mexican-Americans and non-Hispanic whites.
    Haffner SM, Miettinen H, Stern MP, Agil A, Jialal I.
    Metabolism; 1996 Jul; 45(7):876-81. PubMed ID: 8692025
    [Abstract] [Full Text] [Related]

  • 3. Plasminogen activator inhibitor (PAI-1) activity is elevated in Asian and Caucasian subjects with non-insulin-dependent (type 2) diabetes but not in those with impaired glucose tolerance (IGT) or non-diabetic Asians.
    Nagi DK, Mohamed Ali V, Jain SK, Walji S, Yudkin JS.
    Diabet Med; 1996 Jan; 13(1):59-64. PubMed ID: 8741814
    [Abstract] [Full Text] [Related]

  • 4. The homeostasis model in the San Antonio Heart Study.
    Haffner SM, Miettinen H, Stern MP.
    Diabetes Care; 1997 Jul; 20(7):1087-92. PubMed ID: 9203442
    [Abstract] [Full Text] [Related]

  • 5. Hypertriglyceridemia in different degrees of glucose intolerance in a Finnish population-based study.
    Salomaa VV, Tuomilehto J, Jauhiainen M, Korhonen HJ, Stengård J, Uusitupa M, Pitkanen M, Penttila I.
    Diabetes Care; 1992 May; 15(5):657-65. PubMed ID: 1516486
    [Abstract] [Full Text] [Related]

  • 6. Elevated 1-h post-load plasma glucose levels in subjects with normal glucose tolerance are associated with a pro-atherogenic lipid profile.
    Andreozzi F, Mannino GC, Perticone M, Perticone F, Sesti G.
    Atherosclerosis; 2017 Jan; 256():15-20. PubMed ID: 27940375
    [Abstract] [Full Text] [Related]

  • 7. Lipoprotein analyses in varying degrees of glucose tolerance. Comparison between non-insulin-dependent diabetic, impaired glucose tolerant, and control populations.
    Falko JM, Parr JH, Simpson RN, Wynn V.
    Am J Med; 1987 Oct; 83(4):641-7. PubMed ID: 3674053
    [Abstract] [Full Text] [Related]

  • 8. Elevated remnant-like lipoprotein particles in impaired glucose tolerance and type 2 diabetic patients.
    Watanabe N, Taniguchi T, Taketoh H, Kitagawa Y, Namura H, Yoneda N, Kurimoto Y, Yamada S, Ishikawa Y.
    Diabetes Care; 1999 Jan; 22(1):152-6. PubMed ID: 10333918
    [Abstract] [Full Text] [Related]

  • 9. Insulin sensitivity and abdominal obesity in African-American, Hispanic, and non-Hispanic white men and women. The Insulin Resistance and Atherosclerosis Study.
    Karter AJ, Mayer-Davis EJ, Selby JV, D'Agostino RB, Haffner SM, Sholinsky P, Bergman R, Saad MF, Hamman RF.
    Diabetes; 1996 Nov; 45(11):1547-55. PubMed ID: 8866560
    [Abstract] [Full Text] [Related]

  • 10. Androgen activity as a risk factor for impaired glucose tolerance in postmenopausal women.
    Larsson H, Ahrén B.
    Diabetes Care; 1996 Dec; 19(12):1399-403. PubMed ID: 8941471
    [Abstract] [Full Text] [Related]

  • 11. Differences in LDL oxidizability by glycemic status: the insulin resistance atherosclerosis study.
    Schwenke DC, D'Agostino RB, Goff DC, Karter AJ, Rewers MJ, Wagenknecht LE, Insulin resistance atherosclerosis study.
    Diabetes Care; 2003 May; 26(5):1449-55. PubMed ID: 12716803
    [Abstract] [Full Text] [Related]

  • 12. Circulating lipids and cardiovascular risk in newly diagnosed non-insulin-dependent diabetic subjects in India.
    Shelgikar KM, Naik SS, Khopkar M, Bhat DS, Raut KN, Joglekar CV, Gerard ME, Yajnik CS.
    Diabet Med; 1997 Sep; 14(9):757-61. PubMed ID: 9300225
    [Abstract] [Full Text] [Related]

  • 13. Elevated 1-h post-challenge plasma glucose levels in subjects with normal glucose tolerance or impaired glucose tolerance are associated with whole blood viscosity.
    Marini MA, Fiorentino TV, Andreozzi F, Mannino GC, Perticone M, Sciacqua A, Perticone F, Sesti G.
    Acta Diabetol; 2017 Aug; 54(8):775-784. PubMed ID: 28577138
    [Abstract] [Full Text] [Related]

  • 14. Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications.
    Kesavulu MM, Giri R, Kameswara Rao B, Apparao C.
    Diabetes Metab; 2000 Nov; 26(5):387-92. PubMed ID: 11119018
    [Abstract] [Full Text] [Related]

  • 15. Clinical characteristics of type II diabetic subjects consuming high versus low carbohydrate diets in Mexico City and San Antonio, Texas.
    Gonzélez C, Stern MP, Mitchell BD, Valdez RA, Haffner SM, Pérez BA.
    Diabetes Care; 1994 May; 17(5):397-404. PubMed ID: 8062606
    [Abstract] [Full Text] [Related]

  • 16. Visceral adipose tissue accumulation and cardiovascular disease risk profile in postmenopausal women with impaired glucose tolerance or type 2 diabetes.
    Lemieux S, Bédard A, Piché MÈ, Weisnagel SJ, Corneau L, Bergeron J.
    Clin Endocrinol (Oxf); 2011 Mar; 74(3):340-5. PubMed ID: 21092050
    [Abstract] [Full Text] [Related]

  • 17. Transient impaired glucose tolerance in South African Indians does not carry a risk for progression to NIDDM.
    Motala AA, Omar MA, Gouws E.
    Diabetes Care; 1997 Jul; 20(7):1101-7. PubMed ID: 9203444
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.